Also recently, a screen for antiproliferative drugs in breast cancer identified HJNO, a tetrandrine derivative which inhibits BLM DNA binding, unwinding and ATPase activities, diminishing breast cancer cells proliferation (133). This evidence concerns the gene DNAH8 and breast carcinoma.